Home > Drug Search >
  • company_query: AIMM Therapeutics
  •   > 
Drug Filter
Category:
chemistry (12) biology (10)
Status:
Approved (4) NDA Filing (1) Phase Ⅲ (3) Phase Ⅱ (6) Phase Ⅰ (8)
Clinical Stage:
Pending (3) Active (12) Discontinued (3)
Bio-Type:
Whole antibody (5) ADC (4)
Indication:
Acne (1) Acute myeloid Leukemia (AML) (1) Angina pectoris (1) Bladder cancer (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Delayed graft function (1) Urogenital cancer (2) Gastric cancer (1) Heart failure (1) Hypertension (2) Influenza virus infection (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Onychomycosis (1) Ovarian cancer (2) Pancreatic cancer (2) Prostate cancer (2) Psoriasis (1) Renal cell carcinoma (1) Solid tumours (1) Influenza A virus infections (1) Colorectal cancer (1) Neuroblastoma (1) Malignant glioma (1) Systemic inflammatory response syndrome (SIRS) (1) Hairy cell leukemia (1) Lymphoblastic leukaemia (1) Plaque psoriasis (1) Respiratory syncytial virus infection (1) Stargardt’s disease (1) Skin disorders (1) Ventricular dysfunction (1) Shock (1) Cerebral haemorrhage (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top